| Literature DB >> 30077081 |
M Nuti1, I G Zizzari2, A Botticelli3, A Rughetti2, P Marchetti3.
Abstract
In renal cancer emerging treatment options are becoming available and there is a strong need to combine therapies to reformulate and adjourn clinical practice. We here highlight and discuss the need to take advantage of the common immune targets to design combined strategies to increase clinical responses.Entities:
Keywords: Angiogenesis; Immune system; Immunotherapy; Renal carcinoma; TKI
Mesh：
Substances：
Year: 2018 PMID： 30077081 DOI： 10.1016/j.ctrv.2018.07.016
Source DB: PubMed Journal: Cancer Treat Rev ISSN： 0305-7372 Impact factor: 12.111